TrialBritish journal of clinical pharmacology2018

Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β-hydroxysteroid dehydrogenase type-1 inhibitor BMS-823778.

Yaofeng Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.